An Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study
Abstract
Background There is no valid cardiovascular disease (CVD) risk prediction equation for Australians with diabetes. The aim of this study is to develop and validate a multivariate risk function for 5-year cardiovascular risk prediction in Australian type 2 diabetes patients. Methods The Fremantle Diabetes Study is a community-based longitudinal observational study. A total of 1240 type 2 diabetic patients (95.8% of the baseline cohort) with all required risk factor data were followed from baseline (1993-1996) for 5 years or until they experienced a cardiovascular event or died, whichever came first. CVD during follow up was defined as hospitalization for/with myocardial infarction or stroke, and death from cardiac or cerebrovascular causes or sudden death. Validation of the algorithm was performed on an independent diabetic cohort from the Busselton Health Study. Results During 5570 patient-years of follow up, 185 (14.9%) had at least one CVD event and 175 (14.1%) died (57.7% from CVD). Variables in the final model comprised age, sex, prior CVD, ln(urinary albumin : creatinine ratio), lnHbA(1c), ln(high density lipoprotein-cholesterol), Southern European ethnic background and Aboriginality. The mean 5-year predicted risk of a CVD event was 15.5%. Applied to the Busselton cohort, discrimination of the model was good (AUC = 0.84, P Conclusion This simple diabetes-specific 5-year CVD risk equation is the first validated, population-based Australian model. It should have a role in…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
For patients with macroalbuminuria, the 11 mg/mmol difference in mean ACR would represent a 1% lower absolute 5-year risk of cardiovascular disease, based on a diabetes-specific risk calculator.
“in whom the 11 mg/mmol difference in mean ACR would represent a 1% lower absolute 5 year risk of cardiovascular disease, based on a diabetes-specific risk calculator [42].”
Cited by
Sorted by citations
on behalf of the FIELD Study investigators, Davis, T. M. E., Ting, R., Best, J. D., Donoghoe, M. W., Drury, P. L., Sullivan, D. R., Jenkins, A. J., O’Connell, R. L., Whiting, M. J., et al. (2011) · Diabetologia · doi:10.1007/s00125-010-1951-1 · Cited by 371 · see citing works
Self-citationStefan, N., & Schulze, M. B. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00086-4 · Cited by 215 · see citing works
Varney, J. E., Liew, D., Weiland, T. J., Inder, W. J., & Jelinek, G. A. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1645-6 · Cited by 21 · see citing works
Liu, L., Ruan, Z., Ung, C. O. L., Zhang, Y., Shen, Y., Han, S., Jia, R., Qiao, J., Hu, H., & Guo, L. (2023) · Diabetes Therapy · doi:10.1007/s13300-022-01336-7 · Cited by 12 · see citing works
Tan, E. D. D., Davis, W. A., & Davis, T. M. E. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12267 · Cited by 11 · see citing works
Self-citation
- Authors
- Davis, W. A., Knuiman, M. W., & Davis, T. M. E.
- Affiliations
- The University of Western Australia (AU)
- Corresponding author
- Davis, W. A.
- Venue
- Internal Medicine Journal
- Publisher
- Wiley
- Published
- 2010-04
- Volume
- 40
- Issue
- 4
- Pages
- 286-292
- ISSN
- 1444-0903 (ISSN-L)
- 1445-5994
- OpenAlex
- W2019950898
- Cited by
- 83
- References
- 0
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 4 · 2023: 8 · 2022: 9 · 2021: 8 · 2020: 8 · 2019: 2 · 2018: 5 · 2017: 4 · 2016: 4 · 2015: 5 · 2014: 6 · 2013: 5 · 2012: 2
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Update notices
- erratum (2010-05-18)
- Open access
- closed
- Locations
- Internal Medicine Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, cardiovascular risk prediction, risk prediction equations, Fremantle Diabetes Study, Busselton Health Study, cardiovascular events, myocardial infarction, stroke, cardiovascular mortality, urinary albumin-creatinine ratio, HbA1c, HDL cholesterol, Aboriginality, ethnicity, model validation, Australian population
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Australia, Cardiovascular Diseases, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Population Surveillance, Risk Factors, Western Australia, Cohort Studies, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review